Celsis: time to put lab services on the block?
UK company Celsis saw softness in demand across its operating divisions in the third quarter ended December 31, and said it was considering “strategic alternatives” for its laboratory services unit.
UK company Celsis saw softness in demand across its operating divisions in the third quarter ended December 31, and said it was considering “strategic alternatives” for its laboratory services unit.
WIL Research Laboratories has expanded into protein and small molecule bioanalysis and genetic toxicology through the acquisition of Midwest BioResearch.
Deacom has updated its ERP software, which allows a manufacturer to track raw materials through its facility and perform a range of business processes.
Work into solvents that can switch polarity from an ionic to non-ionic form, negating the need to remove them after each step, has won a researcher the John C Polanyi Award.
MannKind, one of the inhaled-insulin market’s only remaining players, has posted higher than expected Q4 losses as costs for development of its lead product candidate Afresa increase ahead of its submission to the US FDA.
Contract research organisation Bio-Imaging Technologies posted a 48 per cent hike on revenues in the fourth quarter of 2008, but still made a small net loss on the back of its CapMed division, which was sold last month.
Valois Pharma is installing precision plastic molding capabilities at its manufacturing facility in Congers, New York, US as part of ongoing efforts to modernise its global manufacturing operations.
Japanese chemicals firm Asahi Kasei has ramped up its bioprocessing operations with the acquisition of US industrial processing specialist TechniKrom’s biopharmaceuticals business.